Patients with heart diseases. Diseases of the circulatory system(I00-I99)
Conditions
Interventions
Intervention 1: **Session 1** will be conducted with the aim of facilitating acquaintance among participants, clarifying expectations, ensuring confidentiality, defining mutual commitments, and explai
Sponsors
Ghoum University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Diagnosis of heart disease confirmed by a specialist doctor Interested in participating in the study Full alertness Not suffering from mental disorders such as depression and anxiety, etc. Absence of serious cognitive disorders such as Alzheimer's or other brain disorders as diagnosed by a specialist physician Absence of acute illnesses with psychological or physical effects that may affect the results of the study, as diagnosed by a doctor or psychologist.
Exclusion criteria
Exclusion criteria: Unwillingness to continue participating in the study Failure to attend more than two out of six meetings Occurrence of specific critical conditions such as the death of loved ones, etc Deterioration of the patient's health status or instability of the clinical condition as diagnosed by a specialist
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In this study, the positive and negative affect refer to the scores obtained from the short version of the International Thompson's Positive and Negative Affect Schedule (PANAS) in cardiac patients. Timepoint: Baseline (T0): Administered prior to the first session.Post-intervention (T1): Conducted immediately after the completion of the 8th session.Follow-up (T2): Administered one month post-intervention to assess the long-term sustainability of the outcomes. Method of measurement: Thompson's Positive and Negative Affect Schedule (PANAS).;The variable of hope, as one of the primary outcomes of the study, will be operationalized through the total score derived from the Snyder Hope Scale (1991). Timepoint: Baseline (T0): Administered prior to the first session.Post-intervention (T1): Conducted immediately after the completion of the 8th session.Follow-up (T2): Administered one month post-intervention to assess the long-term sustainability of the outcomes. Method of measurement: Hope will be assessed using the 12-item Snyder Hope Scale (1991). It will measure agency and pathways thinking on a 4-point Likert scale. Data will be collected at baseline, post-session 8, and follow-up. The questionnaire will be administered digitally via the Porsline platform, and a research assistant will be available to provide technical support. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlireza Mirjalili
Yazd University of Medical Sciences
Outcome results
None listed